Search results summary
From Health Canada
Search criteria
- Status: Select all
- AIG: 0150422001
Search results
| Status | DIN | Company | Product | Class | PM See footnote1 | Schedule | # See footnote2 | A.I. name See footnote3 | Strength |
|---|---|---|---|---|---|---|---|---|---|
| Approved | 02553805 | CELLTRION INC. | OMLYCLO | Human | Yes | Schedule D | 1 | OMALIZUMAB | 75 MG / 0.5 ML |
| Approved | 02553805 | CELLTRION INC. | OMLYCLO | Human | Yes | Prescription | 1 | OMALIZUMAB | 75 MG / 0.5 ML |
| Approved | 02553813 | CELLTRION INC. | OMLYCLO | Human | Yes | Prescription | 1 | OMALIZUMAB | 150 MG / 1 ML |
| Approved | 02553813 | CELLTRION INC. | OMLYCLO | Human | Yes | Schedule D | 1 | OMALIZUMAB | 150 MG / 1 ML |
| Marketed | 02260565 | NOVARTIS PHARMACEUTICALS CANADA INC | XOLAIR | Human | Yes | Prescription | 1 | OMALIZUMAB | 150 MG / VIAL |
| Marketed | 02260565 | NOVARTIS PHARMACEUTICALS CANADA INC | XOLAIR | Human | Yes | Schedule D | 1 | OMALIZUMAB | 150 MG / VIAL |
| Marketed | 02459787 | NOVARTIS PHARMACEUTICALS CANADA INC | XOLAIR | Human | Yes | Schedule D | 1 | OMALIZUMAB | 75 MG / 0.5 ML |
| Marketed | 02459787 | NOVARTIS PHARMACEUTICALS CANADA INC | XOLAIR | Human | Yes | Prescription | 1 | OMALIZUMAB | 75 MG / 0.5 ML |
| Marketed | 02459795 | NOVARTIS PHARMACEUTICALS CANADA INC | XOLAIR | Human | Yes | Schedule D | 1 | OMALIZUMAB | 150 MG / 1 ML |
| Marketed | 02459795 | NOVARTIS PHARMACEUTICALS CANADA INC | XOLAIR | Human | Yes | Prescription | 1 | OMALIZUMAB | 150 MG / 1 ML |
| Marketed | 02545136 | NOVARTIS PHARMACEUTICALS CANADA INC | XOLAIR | Human | Yes | Prescription | 1 | OMALIZUMAB | 75 MG / 0.5 ML |
| Marketed | 02545136 | NOVARTIS PHARMACEUTICALS CANADA INC | XOLAIR | Human | Yes | Schedule D | 1 | OMALIZUMAB | 75 MG / 0.5 ML |
| Marketed | 02545144 | NOVARTIS PHARMACEUTICALS CANADA INC | XOLAIR | Human | Yes | Prescription | 1 | OMALIZUMAB | 150 MG / 1 ML |
| Marketed | 02545144 | NOVARTIS PHARMACEUTICALS CANADA INC | XOLAIR | Human | Yes | Schedule D | 1 | OMALIZUMAB | 150 MG / 1 ML |
| Approved | 02545152 | NOVARTIS PHARMACEUTICALS CANADA INC | XOLAIR | Human | Yes | Prescription | 1 | OMALIZUMAB | 300 MG / 2 ML |
| Approved | 02545152 | NOVARTIS PHARMACEUTICALS CANADA INC | XOLAIR | Human | Yes | Schedule D | 1 | OMALIZUMAB | 300 MG / 2 ML |
| Approved | 02545160 | NOVARTIS PHARMACEUTICALS CANADA INC | XOLAIR | Human | Yes | Schedule D | 1 | OMALIZUMAB | 300 MG / 2 ML |
| Approved | 02545160 | NOVARTIS PHARMACEUTICALS CANADA INC | XOLAIR | Human | Yes | Prescription | 1 | OMALIZUMAB | 300 MG / 2 ML |
Application information
Related information
Contact us
Version 4.0.3